Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The wolf supermoon will kick off 2026 with a celestial bang. Here's when and how to see it. - 2Hilary Duff announces new album ‘Luck… or Something,’ her first in over 10 years: ‘Excited is the largest understatement’
- 3Have gravitational waves provided the first hint of primordial black holes born during the Big Bang?
- 4IDF kills senior PIJ Gaza City Brigade cmdr. who infiltrated Kibbutz Nahal Oz on Oct. 7
- 5Behind every perfect holiday memory is a mom on the brink
- AstraZeneca to acquire Modella AI to speed oncology drug research
- Activists: Venezuela released just nine prisoners despite promise
- ‘Wicked: For Good’ streaming release — How to watch the sequel starring Ariana Grande and Cynthia Erivo
- A Gustav Klimt painting is now the most expensive piece of modern art sold at auction. The fascinating history behind the $236 million 'Portrait of Elisabeth Lederer.'
- The Solution to Ecological Protection: Saving Nature for People in the future
- Is relief in sight? Flu season still brutal but cases are declining.
- A definitive Cruiser Standoff: Decision in favor of Your #1 Ride
- 4 astronauts are en route home from ISS after medical issue forces early exit
- Higher cost, worse coverage: Affordable Care Act enrollees say expiring subsidies will hit them hard
